Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

US Patent 9970938 · Granted May 15, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sample analysis apparatus and sample analysis method2025
Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation m2025
Intracellular kinase associated with resistance against anti-tumour immune respo2025
Cytotoxic T cell response modifiers2023
Pharmaceutical combinations for use in the treatment of neoplastic diseases2022
Pharmaceutical combinations for use in the treatment of neoplastic diseases2022
Sucrose phosphorylase mutant with improved enzyme activity and construction meth2021
17β-hydroxysteroid dehydrogenase mutants and application thereof2021
Method for producing 1,2-amino alcohol compound by whole cell transformation2021
Thermophilic L-asparaginase mutant and screening and fermentation methods thereo2021
Method for producing 9alpha-hydroxy androstane-4-alkene-3,17-diketone by enzymat2021
Aspartase mutant, recombinant expression vector and recombinant bacterium contai2020